Originally published by 12 News KPNX View Original Article
GLP-1 vision loss lawsuits, a new Alzheimer's brain map and ibogaine under scrutiny

GLP-1 vision loss lawsuits, a new Alzheimer's brain map and ibogaine under scrutiny

Dozens of lawsuits claim GLP-1 drugs like Ozempic and Mounjaro caused a rare vision loss, but the science remains mixed.
Read the original article at 12 News KPNX →